StemRIM (TYO:4599)
Japan · Delayed Price · Currency is JPY 293.00
-12.00 (-3.93%)
Sep 16, 2025, 1:44 PM JST
StemRIM Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
44
Market Cap
18.95B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jul 31, 2025 | - | - | - |
| Jul 31, 2024 | - | - | - |
| Jul 31, 2023 | 2.35B | 2.33B | 10,581.82% |
| Jul 31, 2022 | 22.00M | -1.38B | -98.43% |
| Jul 31, 2021 | 1.40B | -700.00M | -33.33% |
| Jul 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jul 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jul 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jul 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Chugai Pharmaceutical | 1,196.21B |
| HOYA Corporation | 876.09B |
| Takeda Pharmaceutical Company | 4,480.25B |
| Daiichi Sankyo Company | 1,924.68B |
| Otsuka Holdings | 2,401.70B |
| Terumo | 1,037.94B |
| Astellas Pharma | 1,944.99B |
| Shionogi & | 440.50B |